We develop MRI quantitative imaging biomarkers for precision diagnosis and treatment
Quantitative Imaging Biomarkers
Medimagemetric LLC is founded on technical and clinical research development of Imaging-based biomarkers. Based on rigorous biophysics and computation, we have developed quantitative imaging biomarkers of tissue function and metabolism for precision diagnosis and treatment. Our technologies include MRI based Quantitative Susceptibility Mapping (QSMetric™), Oxygen Extraction Fraction Mapping (OEFMetric™), and Cerebral Metabolic Rate of Oxygen Mapping (CMRO2Metric™). We are developing multiple metabolic imaging and function-specific imaging methods, including Quantitative Transport Mapping (QTMetric™) . We also provide a robust research product QSM-MEDI™.
